Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 7 MGMT immunohistochemistry

From: Volumetric and MGMT parameters in glioblastoma patients: Survival analysis

  n %
Evaluable results 35/44 79.5
   MGMT absence (≤ 5% positive tumor cells) 18/35 51.4
   MGMT presence (> 5% positive tumor cells) 17/35 48.6
Low MGMT expression (≤ 20% positive) 11/17 64.7
High MGMT expression (> 20% positive) 6/17 35.3